An investigation of the pharmacokinetics, toxicity, and clinical efficacy of neoral cyclosporin in cystic fibrosis patients

Transplantation Proceedings

Volumn 29, Issue 1-2, 1997, Pages 599-601

  Mikhail, G ^a   Eadon, H ^a   Leaver, N ^a   Rogers, P ^a   Stephens, D ^a   Banner, N ^a   Khaghani, A ^a   Yacoub, M ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; CYSTIC FIBROSIS; CYTOTOXICITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; DRUG METABOLISM; FEMALE; GRAFT REJECTION; HEART LUNG TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CHILD; CYCLOSPORINE; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GRAFT REJECTION; HEART-LUNG TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LUNG TRANSPLANTATION; MALE; VITAL CAPACITY;

EID: 0030901017     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(96)00319-3     Document Type: Conference Paper

References (2)

1. Tsang VT, Johnston A, Heritier F: Eur J Clin Pharmacol 46:(3)261, 1994
2. Mikhail G, Eadon H, Leaver N, et al: Transpl Proc 26(5): 2985, 1994